The preimplantation embryo is sensitive to its environment and, despite having some plasticity to adapt, environmental perturbations can impair embryo development, metabolic homeostasis, fetal and placental development, and offspring health. This study used an in vitro model of embryo culture with increasing mitochondrial inhibition to directly establish the effect of impaired mitochondrial function on embryonic, fetal, and placental development. Culture in the absence of the carbohydrate pyruvate significantly increased blastocyst glucose oxidation via glycolysis to maintain normal levels of ATP and tricarboxylic acid (TCA) cycle activity. This culture resulted in a significant reduction in blastocyst development, trophectoderm cell number, and respiration rate but, importantly, did not impair implantation rates or fetal and placental development. In contrast, increasing concentrations of the mitochondrial inhibitor amino-oxyacetate (AOA) impaired glycolysis, TCA cycle activity, respiration rate, and ATP production; incrementally reduced blastocyst development; and decreased blastocyst inner cell mass and trophectoderm cell numbers. Importantly, AOA did not affect implantation rates; however, 5 lM AOA significantly reduced placental growth but not fetal growth, increasing the fetal:placental weight ratio. Furthermore, 50 lM AOA significantly reduced both placental and fetal growth but not the fetal:placental weight ratio. Hence, this study demonstrates that a threshold of mitochondrial function is required for normal development, and despite developmental plasticity of the embryo, impaired mitochondrial function in the embryo affects subsequent fetal and placental growth. These results highlight the importance of mitochondrial function in regulating pre-and postimplantation development; however, the effect on offspring health remains unknown.
INTRODUCTION
It is now recognized that the intrauterine environment can have a profound impact on fetal development and offspring health [1] . Interestingly, gametes and preimplantation embryos are similarly susceptible to their environment, despite having some plasticity to adapt [2, 3] . In vitro environmental perturbations, such as extended culture under suboptimal conditions and/or the presence of serum, not only can confer detrimental effects to embryo development, gene expression, and metabolic homeostasis but importantly can also impair fetal and placental development and postnatal physiology in the mouse [4] [5] [6] , sheep [7, 8] , and cow [9, 10] . In addition, in vitro perturbations have also been associated with changes in offspring behavior [11, 12] . Comparatively less is known about the effects of environmental perturbations in humans; however, a recent study has shown human perinatal outcomes are similarly influenced by culture medium composition [13] . Furthermore, dietary and lifestyle choices can also result in a perturbed in vivo environment and have an impact on embryonic, fetal, and placental development and the health of the subsequent offspring (for example, obesity [14] , undernutrition [15] , high or low protein [16] [17] [18] , or omega-3 fatty acids [19] ).
The mechanisms underpinning perturbed development remain largely unknown; however, impaired mitochondrial function is thought to play a key role. Mitochondria are likely to be susceptible to environmental perturbations, given that they undergo significant changes in their function throughout the preimplantation period [20, 21] , which correlate with changes to their structure [22] . However, mitochondrial DNA (mtDNA) replication remains constant during preimplantation development in the mouse and is not initiated until postimplantation [23, 24] , except possibly for a short period of synthesis following fertilization [25] . Mitochondria are key regulators of many cell functions including calcium regulation, programmed cell death, and ATP production. Their role in energy production is fundamentally important during early oocyte and embryo development [26] , during which mitochondrial oxidative phosphorylation is known to be a major source of ATP production in the oocyte [27] and embryo [28] . ATP levels are associated with oocyte and embryo developmental competence in different species [29, 30] and are required for normal sperm-triggered Ca 2þ oscillations at fertilization [27] . Modulation of mitochondrial function in the early embryo via transient chemical inhibition has been shown to perturb embryo development [31] [32] [33] [34] . Similar reductions in development have been reported following sublethal mitochondrial injury of the oocyte via photosensitization, with increased mitochondrial permeability and apoptotic degeneration [35] as well as impaired postimplantation development [36] . Changes in mitochondrial parameters such as membrane potential and localization are also associated with mammalian embryo developmental competence [37, 38] and are commonly observed in oocytes and embryos following exposure to a range of environmental perturbations [39, 40] . Thus, metabolic homeostasis is associated with embryo development and postimplantation outcomes, and noninvasive measures of metabolism are now used to predict embryo viability [41, 42] .
Research into the changing metabolic profile of the preimplantation embryo has used artificial inhibitors of mitochondrial function during embryonic culture. While mitochondrial inhibition perturbs blastocyst development, the embryos show remarkable plasticity, often adapting metabolically in response to changing nutrient availability [32, 34, 43] . One such inhibitor, amino-oxyacetate (AOA), inhibits the mitochondrial malate aspartate shuttle (MAS). The MAS is crucial in regulating preimplantation embryo metabolism and development [32] [33] [34] and induces a developmental block when added to culture medium before the first cleavage event [31] . Previously we have shown that complete inhibition of the MAS during postcompaction development, using high levels of AOA, has significant developmental consequences, reducing fetal development [34] . However, the extent to which the embryo can adapt to a more moderate level of mitochondrial inhibition, perhaps more reflective of the level of impaired mitochondrial function that might be observed following exposure to a perturbing in vitro or in vivo environment, remains unknown.
Given that mitochondria can be perturbed by exposure to suboptimal environments, we hypothesized that impaired mitochondrial function disrupts fundamental processes important for embryo development and, in turn, effects fetal and placental growth and function. Results of this study aimed to provide direct evidence for the role of mitochondrial function in fetal and placental development and to investigate whether there is a threshold of mitochondrial function required for normal development. To address this, we developed an in vitro model in which embryos were exposed to a continuum of increasing metabolic stress to the blastocyst stage, either by controlled in vitro conditions, such as a deliberate metabolic perturbation induced by culture in the absence of the key carbohydrate pyruvate, or by targeted inhibition of the mitochondrial MAS by addition of the inhibitor AOA. Elucidating the mechanisms that manifest in perturbed development will facilitate the development of improved policies and procedures to minimize or correct the affects of exposure to environments that impair mitochondrial function.
MATERIALS AND METHODS
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO), unless otherwise stated.
Embryo Culture Medium
All embryo handling medium and embryo culture medium was handled and prepared in our laboratory according to our quality control systems [44] , with all chemicals purchased from Sigma-Aldrich, except for GlutaMAX and essential amino acids (Invitrogen, Carlsbad, CA). The initial collection of zygotes was prepared in MOPS-G1 handling medium [45] supplemented with 4 mg/ml bovine serum albumin (BSA) (ICPbio, Auckland, New Zealand). Embryo culture was performed using control or treatment sequential G1.2/G2.2 culture medium [45] with modified vitamins and essential amino acids [46] and supplemented with 5% human serum albumin (Vitrolife, Göteborg, Sweden). Modified treatment medium was prepared without the key carbohydrate pyruvate (ÀP medium) with or without the addition of increasing concentrations (0.5-500 lm) of the mitochondrial MAS inhibitor AOA (AOA-P). This modified treatment medium was used to induce various levels of metabolic perturbations in the preimplantation embryo.
Animals and Embryo Collection
All animal procedures were conducted in accordance with National Institutes of Health guidelines and were approved by the University of Adelaide Animal Ethics Committee.
Female CBAxC57BL/6 mice at 21 days old received 5 IU of equine chorionic gonadotropin (Folligon; Intervet Australia, Bendio, Australia) administered via intraperitoneal injection, followed 48 h later by 5 IU of human chorionic gonadotropin (Pregnyl, Organon, Oss, The Netherlands), and placed with CBAxC57BL/6 males. Females were sacrificed by cervical dislocation 22 h after receiving human chorionic gonadotropin, and oviducts were dissected and collected in warmed MOPS-G1 handling medium. Presumed zygotes were recovered from the ampulla region of each oviduct and exposed to 0.5 mg/ml hyaluronidase for 30 sec to remove any remaining cumulus cells, after which they were washed in MOPS-G1 handling medium.
Embryo Culture and In Vitro Model of Mitochondrial Inhibition
Presumed zygotes were washed in pre-equilibrated G1.2 culture medium, and groups of 10 embryos were placed in 20 ll of G1.2 culture drops under mineral oil and cultured overnight. All culturing was performed at 378C in 5% O 2 and 6% CO 2 .
After 22 h of culture, two-cell embryos were randomly allocated to one of three treatment groups and washed in their respective culture media: 1) control G1.2 medium; 2) G1.2 medium lacking pyruvate (ÀP medium) to deliberately alter embryo metabolism; or 3) G1.2 medium supplemented with 0.5, 5, 50, or 500 lM of the inhibitor AOA in the absence of pyruvate (AOAÀP medium) to inhibit mitochondrial MAS function. Two-cell embryos were then cultured in groups of 10 in 20 ll culture drops in their respective media for the following 24 h, at which time they were again washed and transferred into corresponding G2.2 medium with or without pyruvate and AOA, until the blastocyst stage on Day 5. Developmental rate was assessed on Days 4 and 5 of culture (76 and 93 h of culture, respectively), with all subsequent assessments made on Day 5 blastocyst embryos.
Cell Number and Allocation Measurements
Numbers of trophectoderm (TE) and inner cell mass (ICM) cells were determined in blastocyst stage embryos, using a modification of the technique reported by Hardy et al. [47] as described by Zander et al. [48] . Briefly the zona pelucida of blastocyst stage embryos were removed with 0.5% pronase, before incubation with 10 mM trinitrobenzenesulfonic acid (picric sulfonic acid) for 10 min at 48C, followed by incubation for 10 min in 0.1 mg/ml anti-dinitrophenyl-BSA at 378C. The nuclei of the TE cells were subsequently labeled following incubation, with a complement of guinea pig serum (IMVS, Adelaide, Australia) and 10 lg/ml propidium iodide for 5 min at 378C in the dark, while ICM and TE cells were further labeled with 6 lg/ml bisbenzimide in ethanol overnight. On the following day, embryos were washed in 100% ethanol, mounted in glycerol, and visualized under the ultraviolet filter of a fluorescence microscope. The number of TE cells (pink) and ICM cells (blue) was determined and expressed as a ratio.
Measurements of Blastocyst Apoptosis
Blastocyst stage embryos were assessed for apoptosis by using an in situ cell death detection kit (Roche Diagnostics, Mannheim, Germany). Apoptotic nuclei were fluorescently labeled using terminal deoxynucleotidyl transferasemediated biotin-dUTP nick-end labeling (TUNEL) staining based on methods previously described [49] , while propidium iodide was used to label all cells. Numbers of total and apoptotic nuclei were visualized using fluorescence microscopy (Eclipse TE2000-E model; Nikon Corporation, Tokyo, Japan), and the number of apoptotic cells expressed relative to the total number of cells was used to give an apoptotic cell index value.
Measurement of Respiration Rate
The respiration rate of individual blastocysts was used as a marker of oxidative phosphorylation and was determined according to the manufacturer's instructions, using an EmbryoScope (UniSense A/S, Aarhus, Denmark). Individual embryos were transferred to the bottom of small wells in a precision-made 12-well dish containing their respective culture media. The dish was then inserted into the EmbryoScope for automated recording of O 2 consumption (respiration rate). As the embryo consumes oxygen it generates a linear concentration gradient in the well. The oxygen concentration of each well was measured at predetermined intervals, using an automated microsensor to determine the linear gradient. This concentration gradient was then used to calculate the respiration rate of individual embryos. Measurements were taken approximately every hour for 3 h, with the average respiration rate for the 3 h expressed in femtomoles of oxygen consumed per second (fmol/sec) for each blastocyst.
Analysis of Carbohydrate Metabolism
Rates of glucose oxidation via glycolysis and pyruvate metabolism via the tricarboxylic acid (TCA) cycle were determined for individual embryos as IMPAIRED MITOCHONDRIAL FUNCTION IN THE EMBRYO 573 previously described [4, 50] . Individual blastocyst stage embryos were suspended in 2 ll of their respective G2.2 media containing 0.5 lCi of [5- 
ATP and ADP Determination
Levels of ATP and ADP and the ATP:ADP ratio were determined for individual blastocyst stage embryos by using a modification of the technique reported by Leese et al. [51] , as described by Mitchell et al. [18] . Individual embryos were extracted in 100-nl drops of warmed MOPS-G1 handling medium containing 1mg/ml Ficoll under mineral oil. Following the addition of 20 nl of 3 M perchloric acid, embryos were incubated at 378C for 10 min in the dark. Then, 80 nl of ice-cold 2 M KHCO 3 was added to neutralize the remaining perchloric acid. ATP and ADP concentrations were determined separately for each extraction by using an enzyme-coupled reaction catalyzed by hexokinase and glucose-6-phosphate dehydrogenase or lactate dehydrogenase and pyruvate kinase, respectively, and then quantified using fluorescence microscopy (DMIRB model; Leica, Wetzlar, Germany). Concentrations of ATP and ADP were then determined relative to a standard curve and expressed in picomoles for individual embryos.
Embryo Transfers
Swiss female mice 6-12 weeks old were mated with vasectomized males, and six blastocyst stage embryos were surgically transferred to each uterine horn on Day 3.5 of pregnancy. Each recipient was randomly allocated to receive control embryos in one uterine horn and treatment embryos (from -P or AOA-P culture) in the other. The ability of the embryo to establish a pregnancy was assessed on Day 18 of pregnancy, and the number of fetuses and resorption sites were recorded, along with fetal and placental measurements.
Statistical Analysis
All data are presented as means 6 SEM and were first checked for normality by using a Kolmogorov-Smirnov test and appropriately transformed if necessary. For embryo assessments and pregnancy outcomes, statistical analysis was performed using univariate general linear modeling with SPSS version 15 software (SPSS Inc., Chicago, IL), where differences between treatments were determined using a least significant difference or a Mann-Whitney and KruskalWallis test for nonparametric data. Pair-wise comparisons were used to compare statistical differences between embryo development and cell number data for all treatment groups. The day of culture was fitted as a random factor where appropriate, and development data, expressed as percentages, were also weighted for the number of embryos. For fetal and placental measures, the recipient was additionally fitted as a random factor. Details of the number of embryos, culture replicates, and recipient females for embryo transfer are described for each experiment in the respective tables and figure legends.
RESULTS

Effect of Mitochondrial Inhibition on Embryo Development
Exposure to ÀP culture medium resulted in a significant decrease in the percentage of two-cell embryos that reached the blastocyst stage at 76 h (P , 0.01) ( Table 1 ) and 93 h of culture (P , 0.05) ( Table 1 ) compared to that of control embryos. Furthermore, the decrease after 76 h was due to a significant increase in the percentage of embryos remaining at the morula stage (P , 0.01) ( Table 1) .
Increasing concentrations of AOA (0.5-500 lM) in the absence of pyruvate resulted in a significant decrease in the percentage of two-cell embryos that reached the blastocyst stage at 76 h compared to control embryos (P , 0.01) ( Table  1) . This reduction was due to an increase in the percentage of delayed embryos (P , 0.01) ( Table 1) . Furthermore, AOA inhibition resulted in a dose-dependent decrease in the percentage of blastocyst stage embryos after 93 h of culture (P , 0.01), with just 10.5% of embryos reaching the blastocyst stage following incubation in 500 lM AOA compared to 98.2% for controls ( Table 1) . As a result, the 500 lM AOA treatment was eliminated for subsequent embryo assessments as the embryos were unlikely to be viable.
Effect of Mitochondrial Inhibition on Blastocyst Cell Number and Allocation
ÀP culture or 0.5 lM AOA culture significantly reduced blastocyst cell number compared to controls (P , 0.05), due Table 2 ). There was a small decrease in the number of ICM cells; however, this did not reach statistical significance, and the ICM:TE cell ratios were not significantly different compared to that of controls (Table 2 ). Mitochondrial inhibition with 5 or 50 lM AOA significantly decreased blastocyst cell number compared to that of controls (P , 0.01) ( Table 2 ) and significantly reduced the numbers of both TE and ICM cells (P , 0.05 and P , 0.01, respectively). The reduction in both cell lines resulted in comparable ICM:TE ratios following both 5 and 50 lM AOA treatments (Table 2) . Treatment with 0.5 lM AOA resulted in embryo development comparable to that with ÀP medium, and this treatment group was therefore excluded from further analysis.
Effect of Mitochondrial Inhibition on Apoptosis in the Blastocyst
Apoptotic nuclei were visualized via TUNEL staining and observed in both the ICM and the TE cells in all groups. The ÀP culture did not affect the number of TUNEL-positive cells in blastocyst stage embryos (Table 2 ) but resulted in a small increase in the apoptotic cell index due to the decrease in overall cell numbers (P , 0.05) ( Table 2 ). Culture in the presence of 5 lM AOA did not significantly affect the number of TUNEL-positive cells or the apoptotic cell index compared to that of controls (Table 2) . Culture with 50 lM AOA significantly reduced the number of apoptotic cells compared to that in control cultured embryos (P , 0.05) (Table 2) , although, due to the substantial decrease in cell number, this resulted in a small increase in apoptotic cell index (P , 0.05) ( Table 2) .
Effect of Mitochondrial Inhibition on Carbohydrate Metabolism in the Blastocyst
Blastocysts in ÀP culture showed an 82% increase in glucose oxidation via glycolysis compared to control embryos (P , 0.01) (Fig. 1a) . In contrast, 5 lM AOA resulted in a small reduction in glycolysis (P , 0.01), while 50 lM AOA further decreased glycolysis compared to controls (P , 0.01) (Fig. 1a) .
Similarly, mitochondrial inhibition with AOA incrementally reduced TCA cycle activity compared to that of control embryos (P , 0.01); however, TCA cycle activity was not affected by ÀP culture (Fig. 1b) .
Effect of Mitochondrial Inhibition on Blastocyst Respiration Rate
Oxygen consumption was measured as a marker of mitochondrial oxidative phosphorylation. Treatment in ÀP culture resulted in a significant decrease in respiration rate (P , 0.05) (Fig. 1c) . Furthermore, 5 lM AOA and 50 lM AOA incrementally reduced respiration rates compared to that of control embryos (P , 0.05 and P , 0.01, respectively) (Fig.  1c) .
Effect of Mitochondrial Inhibition on ATP and ADP Production
Exposure to ÀP culture did not affect the levels of ATP compared to control embryos (Fig. 2a) but did increase ADP levels (P , 0.05) (Fig. 2b) , resulting in a trend toward a small decrease in the ATP:ADP ratio (P ¼ 0.08) (Fig. 2c) . Culture with 5 lM AOA significantly reduced ATP levels (P , 0.05) (Fig. 2a) , increased ADP levels (P , 0.05) (Fig. 2b) , and 
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reduced the ATP:ADP ratio compared to that of controls (P , 0.05) (Fig. 2c) . The 50 lM AOAÀP culture further decreased ATP (P , 0.01) (Fig. 2a) and ADP levels (P , 0.08) (Fig. 2b) , resulting in a further reduction in the ATP:ADP ratio compared to control culture (P , 0.05) (Fig. 2c) .
Effect of Increasing Mitochondrial Inhibition on Fetal and Placental Parameters
Implantation rates and fetal survival were unaffected by the absence of pyruvate following embryo transfer (P . 0.05, data not shown). Neither fetal weight, placental weight, fetal:placental weight ratio, crown-to-rump length, nor placental diameter was affected by the absence of pyruvate (P . 0.05, data not shown).
Although culture with AOA did not have an impact on implantation rates or fetal survival (Table 3) , AOA incrementally impaired fetal and placental development (Fig. 3, a-e) . While 5 lM AOA significantly reduced placental weight (P , 0.05) (Fig. 3b) , fetal weight remained comparable to that of controls (Fig. 3a) , resulting in a significant increase in the fetal:placental weight ratio (P , 0.01) (Fig. 3c) . In addition, placental diameter and crown-to-rump length values were comparable between embryos from 5 lM AOA culture and control culture embryos (Fig. 3, d and e). Mitochondrial inhibition with 50 lM AOA significantly decreased both fetal (P , 0.05) (Fig. 3a) and placental weights (P , 0.01) (Fig. 3b) but not the fetal:placental weight ratio (Fig. 3c) . Furthermore, 50 lM AOA reduced placental diameter (P , 0.05) (Fig. 3d ) and tended to decrease fetal crown-to-rump length (P ¼ 0.07) (Fig. 3e) .
DISCUSSION
The environment to which an embryo is exposed can profoundly influence mitochondrial function and subsequent developmental outcomes. This study has developed an in vitro embryo culture model, with incremental increases in mitochondrial inhibition, to directly establish how increases in mitochondrial dysfunction affect embryo, fetal, and placental development. Importantly, we have determined that a threshold of mitochondrial function is required for normal development and have shown that incremental perturbations in mitochondrial function affect not only embryo development but also fetal and placental development with increasing magnitude. Thus, results of this study show that impaired mitochondrial function in the embryo, which is known to occur following exposure to a wide range of environmental perturbations, can have significant developmental consequences.
To induce minor metabolic adaptation but not direct mitochondrial inhibition, embryos were cultured in the absence of pyruvate. Pyruvate, which is metabolized in the mitochondria, is a key energy substrate during precompaction 3 . Effect of mitochondrial inhibition on the embryo on Day 18 for fetal outcomes following embryo transfer for fetal weight (a), placental weight (b), fetal:placental weight ratio (c), fetal crown-to-rump length (d), and placental diameter (e). Data are expressed as means 6 SEM and represent 54 and 36 fetus and placenta pairs for control and 5 lM AOA culture, respectively, and 17 and 14 fetus and placenta pairs for control and 50 lM AOA culture, respectively. Symbols represent significant differences compared to controls: *, P , 0.05; **, P , 0.01; , P , 0.07. [21, [52] [53] [54] . In contrast, the postcompaction stage embryo relies predominantly on glucose [21] , which is metabolized to pyruvate in the cytoplasm, with the co-conversion of NAD þ to NADH. Maintaining the balance of cytosolic and mitochondrial metabolism is important for both embryonic and fetal development [55, 56] and is, in part, regulated by the mitochondrial MAS. The MAS is functional from the two-cell stage and maintains the balance of cytoplasmic and mitochondrial NAD þ to NADH, which are impermeable to the mitochondrial matrix [33] . Hence, embryos cultured in the absence of pyruvate are forced to adapt and utilize lactate or glucose as an energy source. Following culture in the absence of pyruvate, embryos are dependent on the MAS for the regeneration of cytoplasmic NAD þ , necessary for continued cytosolic metabolism of glucose and mitochondrial oxidative phosphorylation. To induce impaired mitochondrial function, this adaptation was then systematically inhibited by the addition of increasing concentrations of the mitochondrial MAS inhibitor AOA in the absence of pyruvate. This condition therefore reduces the ability of the MAS to maintain cytosolic NAD þ and decreases substrate availability for both glycolysis and oxidative phosphorylation.
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This study demonstrates that embryos are able to adapt to culture in the absence of pyruvate, compensating for the altered nutrient environment by increasing the amount of glucose metabolized in the cytoplasm via glycolysis. Consequently, overall mitochondrial function was maintained, with normal levels of mitochondrial pyruvate oxidation via the TCA cycle, and, importantly, normal ATP levels, with just a small decrease in respiration rate. This metabolic plasticity ensured that the absence of pyruvate resulted in only a small decrease in percent blastocyst formation and total cell number and, more importantly, maintained normal implantation rates and fetal and placental development. Interestingly, despite glycolysis being negatively correlated with embryo viability [4, 56, 57] , similar adaptive increases in glucose metabolism have been observed following inhibition of oxidative phosphorylation in precompaction embryos [43] and, in our previous study following complete MAS inhibition, restricted to postcompaction development only [34] . Furthermore, similar metabolic adaptations are also seen in response to suboptimal environments in which embryos compensate for a lack of glucose by maintaining pyruvate uptake postcompaction [58, 59] , where it would normally decline [21] . Therefore treatment in -P medium highlights the remarkable plasticity of the preimplantation embryo and the extent to which it can adapt to allow normal fetal and placental development.
In contrast to the metabolic plasticity observed in embryos following incubation in ÀP culture, direct incremental inhibition of mitochondrial function with AOA resulted in significant and stepwise reductions in cytoplasmic and mitochondrial metabolism. Increasing AOA concentration incrementally reduced mitochondrial metabolism of pyruvate via the TCA cycle, respiration rates, ATP levels, and cytoplasmic metabolism of glucose via glycolysis. This increasing mitochondrial dysfunction and inability to adapt metabolically corresponded with similar stepwise reductions in the embryo's development and cell numbers. Interestingly, a high concentration (500 lM AOA) essentially prevented blastocyst formation, despite our previous findings that this same level of AOA supported normal rates of blastocyst formation when inhibition was restricted to postcompaction development only [34] . Perhaps of most significance was our finding that direct mitochondrial inhibition impaired fetal and placental development, with the degree of impaired development associated with increasing inhibition. Results of this study are in keeping with the impaired fetal development observed following decreased glycolysis and pyruvate metabolism caused by embryos cultured in the presence of ammonium, where it was proposed that this may be due to ammonium's interference with the MAS [4] .
Impaired postimplantation outcomes have also recently been reported following depletion of mtDNA in the oocyte [60] . It is unlikely, however, that the metabolic perturbations and developmental outcomes we report here following mitochondrial inhibition from the two-cell stage are consequences of mtDNA depletion. This is because mtDNA replication, for example, in the mouse is thought not to be initiated until postimplantation [23, 24] , except for a possible short period of synthesis following fertilization [25] ; hence, mtDNA content remains constant during preimplantation development. Therefore, our study demonstrates that despite being able to adapt to a minor metabolic perturbation (e.g., ÀP), the embryo has a threshold whereby it can no longer compensate for compromised mitochondrial function (e.g., AOA treatments), resulting in impaired fetal and placental growth.
The observed decrease in placental growth following mitochondrial inhibition with AOA is of particular significance, given that correct placental growth and function are essential for normal fetal development and are thought to play a crucial role in fetal programming [61, 62] . While birth weight can be a predictor of offspring health [63] , early perturbations can also manifest later in postnatal life, without having a direct impact on fetal weight [17, 64] . Furthermore, it has been suggested that the overall placental phenotype could be considered a better indication of intrauterine environmental perturbation and therefore offspring health, as the placenta has been shown to have a reserve capacity whereby it can adapt both functionally and morphologically to preserve fetal growth [62, 65, 66] . It is therefore perhaps not surprising that in our model of impaired mitochondrial function, we observed similar placental plasticity, whereby a significant reduction in placental weight as a consequence of mitochondrial inhibition with 5 lM AOA was initially able to maintain fetal growth, indicating increased placental function. However, following a greater level of mitochondrial inhibition induced with 50 lM AOA, placental growth was further compromised and unable to adequately compensate, resulting in reduced fetal weight, again suggestive of a threshold effect similar to that observed in the embryo. Furthermore, given that TE cells are precursor cells for the placenta and are more metabolically active and have a greater reliance on mitochondrial metabolism than ICM cells [67, 68] , it is not unexpected that it was placental development that was initially compromised following mitochondrial inhibition with AOA. While this adaptation is no doubt intended to confer optimal fetal development, it remains unclear as to the longterm effect on the offspring with respect to their health.
Interestingly, the numbers of ICM cells, precursors to the embryo proper, and total cells in the blastocyst were correlated with fetal development following embryo transfer [56] . This would suggest that -P embryos would have impaired fetal parameters, as would those cultured in the presence of 5 or 50 lM AOA. While we observed a significant reduction in fetal weight following 50 lM AOA treatment, normal fetal weights were maintained following treatments with -P and 5 lM AOA cultures. Hence, in this study, blastocyst cell numbers did not always correlate with fetal development, perhaps due to the small decrease in ICM cells after culture in -P and 5 lM AOA media. Similarly, blastocyst cell numbers were reported not to correlate with fetal weights following maturation of mouse oocytes under different oxygen concentrations [69] . Despite 578 this, the observed decrease in TE cell number for all treatments relative to that of controls may contribute to the reduction in placental weights observed.
A possible cause for the reduction in blastocyst cell numbers reported here could be a reduced rate of mitosis; however, programmed cell death (apoptosis) is commonly observed in mammalian preimplantation embryos and could also regulate blastocyst cell numbers [70] . An increase in apoptosis was observed following culture under suboptimal conditions [4, 49] and, importantly to this study, has been linked to impaired oocyte and embryo metabolism [35, 71] . The increase in apoptotic cell index for -P and 50 lM AOA cultured embryos may partially account for reduced cell number; however, it represents only a small portion of the cells. Therefore, it is more likely that the decrease in blastocyst cell numbers observed following mitochondrial inhibition was primarily due to reduced mitotic proliferation as a consequence of reduced energy availability.
This model of increasing metabolic inhibition in the embryo suggests that impaired mitochondrial function is potentially one of the key mechanisms underpinning the perturbations in developmental outcomes seen as a consequence of exposure to altered in vivo or in vitro environments, such as the presence of ammonium [4] , suboptimal culture conditions [57] , or as a result of maternal dietary protein intake [16] [17] [18] . Such unfavorable environments result in developmental perturbations of various intensities; however, they consistently induce an array of altered metabolic parameters in the embryo. This study highlights the importance of preimplantation mitochondrial function for regulating embryo development and indicates that reduced mitochondrial function can compromise fetal and placental outcomes. Importantly, we have addressed just one aspect of mitochondrial function, which is known to be necessary for early development. However, the type of mitochondrial perturbation, the duration and intensity of this impairment, and the developmental stage at which the mitochondrial perturbation occurs are likely to determine the consequences for subsequent development. Importantly, the targeted approach used in this study enabled us to directly examine the effect of impaired mitochondrial function of increasing magnitude without the complications of other confounding environmental factors.
In conclusion, the experimental model used here has highlighted the developmental plasticity of the embryo and its ability to adapt to altered nutrient availability. Although the placenta initially preserved fetal growth (e.g., at 5 lM AOA), an incremental increase in mitochondrial inhibition (to 50 lM AOA) was detrimental, suggesting that a threshold level of metabolism is required for normal development and that beyond this threshold, impaired mitochondrial function can compromise fetal and placental growth. These results provide insight into one of the key potential mechanisms that may underpin developmental programming and raise further questions regarding the potential health and disease susceptibility of subsequent offspring. With this enhanced understanding, we can optimize the in vitro and in vivo environment to which an embryo is exposed, potentially improving pregnancy outcomes and offspring viability.
